16S rRNA deep sequencing identifies Actinotignum schaalii as the major component of a polymicrobial intra-abdominal infection and implicates a urinary source by Bryan, Andrew et al.
16S rRNA deep sequencing identifies Actinotignum schaalii as
the major component of a polymicrobial intra-abdominal
infection and implicates a urinary source
Andrew Bryan,1 Lindsey M. Kirkpatrick,2 John J. Manaloor2 and Stephen J. Salipante1,*
Abstract
Introduction. It can be difficult to catalogue the individual organisms comprising polymicrobial patient infections, both
because conventional clinical microbiological culture does not facilitate the isolation and enumeration of all members of a
complex microbial community, and because fastidious organisms may be mixed with organisms that grow rapidly in vitro.
Empiric antimicrobial treatment is frequently employed based on the anatomical site and the suspected source of the
infection, especially when an appropriately collected surgical specimen is not obtained.
Case presentation. We present a case of an intra-abdominal infection in a patient with complex anatomy and recurrent
urinary tract infections. Imaging did not reveal a clear source of infection, no growth was obtained from urine cultures and
initial abdominal fluid cultures were also negative. In contrast, 16S rRNA deep sequencing of abdominal fluid samples
revealed mixed bacterial populations with abundant anaerobes, including Actinotignum schaalii (Actinobaculum schaalii).
Ultimately, only Enterobacter cloacae complex and meticillin-resistant Staphylococcus aureus, both of which were identified by
sequencing, were recovered by culture.
Conclusion. The clinical application of 16S rRNA deep sequencing can more comprehensively and accurately define the
organisms present in an individual patient’s polymicrobial infection than conventional microbiological culture, detecting
species that are not recovered under standard culture conditions or that are otherwise unexpected. These results can
facilitate effective antimicrobial stewardship and help elucidate the possible origins of infections.
INTRODUCTION
Complex intra-abdominal infections pose both diagnostic
and therapeutic dilemmas given their frequent polymi-
crobial nature [1, 2]. Empiric, broad-spectrum therapy is
recommended, with adjustments if unusual organisms or
resistant isolates are identified [1, 3]. However, culturing
fastidious and/or anaerobic organisms from such infec-
tions can be challenging, and may be confounded by
co-infection with organisms that grow rapidly in vitro
[4–6]. Here, we report an intra-abdominal infection
marked by a complex, polymicrobial community contain-
ing Actinotignum schaalii (Actinobaculum schaalii) as the
major species. This fastidious organism was detected by
16S rRNA deep sequencing, whereas only Enterobacter
cloacae complex and Staphylococcus aureus, which were
lesser components of the infectious process, were identi-
fied by culture-based methods.
CASE REPORT
A 21-year-old woman with a history of myelomeningocele,
ventriculoperitoneal shunt, and neurogenic bowel and bladder
presented to an outside hospital with acute worsening of a 1
year history of intermittent abdominal pain and distension.
Her history was significant for remote Malone anterograde
continence enema and Monti procedures to attain faecal and
urinary continence (requiring frequent catheterization), recur-
rent urinary tract infections (UTIs), and bladder perforation
and repair. She was diagnosed with a UTI and discharged on
ciprofloxacin. Urinalysis at the time of the initial presentation
to the outside hospital revealed: specific gravity 1.025; pH 6;
hazy; trace ketones and proteins; small leukocyte esterase; 20–
30 white blood cells per high powered field; 10–20 red blood
cells per high powered field; positive for nitrites; moderate
bacteria; mucous; and no glucose/urobilinogen present. Rou-
tine urine cultures were ultimately negative. Her symptoms
Received 4 January 2017; Accepted 23 March 2017
Author affiliations:
1Department of Laboratory Medicine, University of Washington, Box 357110, 1959 NE Pacific Street, NW120, Seattle, WA, USA; 2Ryan
White Center for Pediatric Infectious Diseases and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN,
USA.
*Correspondence: Stephen J. Salipante, stevesal@uw.edu
Keywords: polymicrobial; Actinotignum shaalii; 16S rRNA; deep sequencing; abdominal; urinary tract infection.
Abbreviations: CT, computed tomography; HD, hospital day; UTI, urinary tract infection; WBC, white blood cell.
CASE REPORT
Bryan et al., JMM Case Reports 2017;4
DOI 10.1099/jmmcr.0.005091
005091 ã 2017 The Authors
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, distribution and reproduction in any medium, provided the original
author and source are credited.
1
worsened over the following 2 days and she presented to a
paediatric hospital, where she was found to be diaphoretic
with middle left quadrant and epigastric abdominal pain and
a distended abdomen. Laboratory test results were notable for
leucocytosis (18 500 cellsmm 3) without left shift and a uri-
nalysis that was not concerning for infection (pH 6, negative
for nitrites and leukocyte esterase, and no microscopic evi-
dence of WBCs or red blood cells). Urine cultures were col-
lected: blood agar and MacConkey plates (Remel) were
incubated for at least 18 h at 35

C under ambient air and were
finalized as no growth. Antimicrobials were initially stopped
at the paediatric hospital given the initial urine studies did not
indicate a UTI, lack of fever, stable vital signs and baseline
abdominal distension. Ciprofloxacin, which she had taken
inconsistently as an outpatient, was discontinued. A computed
tomography (CT) cystogram and CT scan of the pelvis
(Fig. 1) and an ultrasound (not shown) demonstrated complex
abdominal fluid collection, but no evidence of bladder
perforation.
Three days after admission to the paediatric hospital [hospi-
tal day (HD) 3], a percutaneous drain was put in place.
Fluid studies revealed 1010 nucleated cells ml 1 (97% neu-
trophils), <0.5 g albumin dl 1, <10 units amylase l 1, 38mg
glucose dl 1, 460 units lactate dehydrogenase l 1 and
0.2mg fluid creatinine dl 1. Gram stain showed 1+ WBC,
but no organisms. Abdominal fluid cultures were plated on
blood, chocolate, MacConkey, CNA (colistin and nalidixic
acid), PEA (phenylethyl alcohol) and anaerobic blood agar
media (Remel). The patient was administered piperacillin/
tazobactam and then transitioned to cefepime on HD14
after recurrent fever and isolation of E. cloacae complex, as
described below. Upon the switch to cefepime, metronida-
zole was added for improved anaerobic coverage. Aerobic
(5–10% CO2) and anaerobic abdominal fluid cultures
remained negative after 5 days of incubation at 35

C.
The patient’s ventriculoperitoneal shunt was externalized
on HD5. She was started on vancomycin on HD9 after
developing pustules around her abdominal incision site.
Repeat CT cystogram showed a rim enhancing pelvic fluid
collection and a Malone anterograde continence enema
fluoroscopic study showed a patent colon without stricture
or urethral fistula. Her abdominal drain was exchanged on
HD10, at which time fluid was again submitted for culture
on solid media. Abdominal fluid was also inoculated at the
bedside into aerobic and anaerobic blood culture bottles
(BD BACTEC Plus) and sent for broad-range bacterial 16S
rRNA PCR (Clinical Microbiology Laboratory, University
of Washington, Seattle, WA, USA).
Conventional 16S rRNA Sanger sequencing [7] resulted in
an uninterpretable chromatogram, suggestive of multiple
bacterial templates. Therefore, 16S rRNA deep sequencing
(Illumina MiSeq) was performed with data processing and
sequence classification as previously described [4, 6, 8]. A
total of 4 94 324 raw sequence reads were obtained. Taxo-
nomic classification by deep sequencing identified multiple
organisms, with the highest number of reads corresponding
to A. schaalii (Table 1). E. cloacae complex grew from both
the aerobic and anaerobic blood culture bottles, while metic-
illin-resistant S. aureus grew from the aerobic blood culture
bottle. Solid media did not recover any organisms after 5
days of incubation.
The patient underwent tPA (tissue plasminogen activator)-
mediated lysis of her fluid collection and was discharged
after 21 days on vancomycin, cefepime and metronidazole,
eventually completing 45 days of therapy with resolution of
signs and symptoms.
DISCUSSION
Approximately 3 in 10 000 live births are affected by spina
bifida, with the majority having neurogenic bladder [9]. Over
40% of those patients will have >5UTIs by age 15 years [9–
12]. The complex anatomy, procedural history and antimicro-
bial exposure in our patient further increased her risk for UTI
with a broad range of pathogens that may differ from uncom-
plicated community-acquired infections [9–12]. Imaging and
fluid chemistry studies, including creatinine, did not implicate
a specific source of infection. The differential was conse-
quently broad and included the cerebrospinal fluid /shunt,
genitourinary system and gastrointestinal tract.
Although only E. cloacae complex and meticillin-resistant S.
aureus were isolated by culturing patient specimens; 16S
rRNA deep sequencing enumerated a polymicrobial popula-
tion (Table 1), which was predominantly composed of A.
schaalii. In total, six of the eight organisms identified by
sequencing were not recovered by conventional techniques.
(a) (b)
(c) (d)
Fig. 1. (a, b) Axial cross-section from CT of the abdomen and pelvis
demonstrating: small volume pelvic fluid collection 1 year prior to the
illness (a) and large pelvic fluid collection at the time of admission (b).
(c, d) Coronal cross-section from contrasted CT cystogram demon-
strating no detectable extravesicular dye in the abdomen and pelvis
on admission: pre-void (c) and post-void (d).
Bryan et al., JMM Case Reports 2017;4
2
These results are consistent with controlled experiments,
which have indicated that standard culture conditions either
fail to recover or significantly distort the relative abundance
of organisms present in polymicrobial samples [4]. A. schaa-
lii, in particular, is challenging to grow and to phenotypi-
cally characterize [13]. Although the standard urine culture
conditions used in this case would not have recovered A.
schaalii, the organism can be isolated on blood agar plates
incubated at 5% CO2 for 48 h [13, 14]. This suggests that
culture of the body fluid could have supported growth of
the organism, but that the organism was either non-viable
at the time of sampling due to prolonged antimicrobial
exposure or was outcompeted in vitro by the more rapidly
growing S. aureus or E. cloacae.
The detection of A. schaalii was suggestive of a urinary aeti-
ology for the patient’s infection, possibly a bladder micro-
perforation [13, 15, 16]. In support of this hypothesis, most
of the additional organisms recovered by 16S rRNA
sequencing have also been reported in varying abundances
in urine [15, 17–21]. The normal fluid creatinine suggests a
time frame sufficient for autodialysis of extravasated urine,
and supports the subacute to chronic onset of infection
rather than an acute urological pathology [22, 23]. However,
given the patient’s anatomy, it is also possible that skin and
gastrointestinal microbiota were contributory.
A. schaalii has been an infrequently described, but likely
under-recognized cause of UTIs and abdominal abscesses
[13]. Despite studies showing a prevalence in urine of
greater than 15% by PCR [24], it is rarely isolated in urine
cultures given its slow growth (~48 h) and a requirement
for low-oxygen conditions. The organism’s identification
has also been historically complicated by challenges with
biochemical identification methods, although this has been
remedied in laboratories that have adopted matrix-assisted
laser desorption ionization-time of flight mass spectrome-
try [13, 14, 25, 26]. The human ecological niche appears to
be primarily the genitourinary system [27]. Although typi-
cally susceptible to b-lactams and vancomycin, A.
schaalii is frequently resistant to macrolides, clindamycin,
trimethoprim/sulfamethoxazole, metronidazole and
fluoroquinolones [13, 28]: many of the agents typically used
to treat UTIs and for potential de-escalation of therapy for
complex intra-abdominal infections. In this case, the anae-
robes identified by sequencing are typically susceptible to
b-lactams, while resistance rates to clindamycin may be up
to 40% for Peptoniphilus and Finegoldia magna [19, 29]. Of
note, Bacteroides spp., typically among the most drug-resis-
tant anaerobic organisms, were not identified (Table 1)
[29]. De-escalation of antimicrobials was challenging in this
case given the simultaneous identification of meticillin-
resistant S. aureus and Enterobacter; however, source con-
trol and b-lactam therapy should have been sufficient for
the anaerobes identified [29].
This case demonstrates the utility of 16S rRNA deep
sequencing in patient management. Organisms with spe-
cific ecological niches and microbiological culture require-
ments were identified far more comprehensively by
sequencing, but were not recovered by standard clinical
culture, providing insight into the aetiology of the patient’s
infection. To our knowledge, the application of 16S rRNA
deep sequencing or metagenomics of clinically infected
individual patient samples has not been previously
described as a tool to help determine the route of a
patient’s infection. Even though many fastidious organ-
isms, such as A. schaalii, can be recovered using suffi-
ciently broad culture conditions [30], it is not possible to
anticipate the relevant organisms in all specimens and
there are practical limits to the number of plates that can
be applied per specimen. High-throughput sequencing is
inherently scalable, and able to recover species unbiasedly
and without prior expectation [4]. Moreover, accurate
characterization of polymicrobial infections can facilitate
appropriate escalation or de-escalation of therapy, while
minimizing exposure to broad-spectrum antimicrobials
and supporting antibiotic stewardship. Further integration
of high throughput 16S rRNA sequencing with clinical
practice has the potential to improve patient care [4].
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Table 1. Organisms identified by 16S rRNA deep sequencing
Reads Per cent of total reads* Per cent identity Assignment
91 897 34.09 99.03–100.0 Actinotignum schaalii
2 02 293 30.53 99.01–100.0 Bacteria of family Enterobacteriaceae†
38 800 10.8 97.22–100.0 Peptoniphilus species related to Peptoniphilus indolicus
35 435 7.89 99.01–100.0 Staphylococcus aureus
23 612 5.84 99.02–100.0 Campylobacter ureolyticus
16 970 4.72 99.08–100.0 Helcococcus kunzii
12 852 3.58 99.04–100.0 Finegoldia magna
4 738 1.27 97.03–99.34 Anaerococcus species
*Percentage of total reads corrected for abundance of rRNA sequences; only organisms with abundances >1% are shown.
†The 16S rRNA V1-V2 region does not permit reliable species-level classifications within the family Enterobacteriaceae.
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